Search

everythinglearnresearchcommunity

for

Search:↓

A temporary capillary cell type helps skin repair after radiation by promoting blood vessel growth.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Gut bacteria may influence hair loss in alopecia areata.

Advances in RNA research and skin models offer hope for better skin healing without scarring.

Older mice healed wounds better but lost more weight and might have weaker immune systems afterward.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Defective repair processes may cause immune activation and inflammation in psoriatic disease.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Developing human skin has immune cells with memory-like features.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Leflunomide is more likely to help treat alopecia areata than cause it.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.